Osteoarthritis: an overview of the disease and its treatment strategies
- PMID: 16084227
- DOI: 10.1016/j.semarthrit.2005.01.013
Osteoarthritis: an overview of the disease and its treatment strategies
Abstract
Osteoarthritis (OA) is currently defined by the American College of Rheumatology as a "heterogeneous group of conditions that leads to joint symptoms and signs which are associated with defective integrity of articular cartilage, in addition to related changes in the underlying bone at the joint margins." Its prevalence after the age of 65 years is about 60% in men and 70% in women. The etiology of OA is multifactorial, with inflammatory, metabolic, and mechanical causes. A number of environmental risk factors, such as obesity, occupation, and trauma, may initiate various pathological pathways. OA indicates the degeneration of articular cartilage together with changes in subchondral bone and mild intraarticular inflammation. The principal treatment objectives are to control pain adequately, improve function, and reduce disability. Acetaminophen is frequently used for symptomatic OA with mild to moderate pain. Nonsteroidal antiinflammatory drugs (NSAIDs) are more effective in the case of moderate-severe pain, but they have an increased risk of serious upper gastrointestinal adverse events. The newer cyclooxygenase COX-2 specific inhibitors (Coxibs) are as efficacious as traditional NSAIDs and have a better gastrointestinal safety profile. Other compounds (eg, chondroitin sulfate, diacerein, glucosamine sulfate) have a symptomatic effect that is slower and less than that of NSAIDs. The structure-modifying effects of drugs are currently being evaluated, and both glucosamine sulfate and diacerein have been shown in some trials to have a beneficial structural effect. Nonpharmacological interventions are frequently and widely used in the management of OA patients, but there is little evidence that they are effective: the best studied and most successful nonpharmacological interventions are patient education, self-management, and exercise. There is some evidence for the pain-relieving efficacy of thermotherapy and transcutaneous electrical nerve stimulation (TENS) but not of electrotherapy, acupuncture, homeopathy, or manual therapy. The value of interventions aimed at improving function and maximizing independence (occupational therapy, walking aids, workplace adaptation) is also unclear. The disease course and patient's requirements often change over time, thus requiring a periodic review and readjustment of therapy rather than the rigid continuation of a single treatment.
Similar articles
-
Comorbid conditions in the AMICA study patients: effects on the quality of life and drug prescriptions by general practitioners and specialists.Semin Arthritis Rheum. 2005 Aug;35(1 Suppl 1):31-7. doi: 10.1016/j.semarthrit.2005.02.004. Semin Arthritis Rheum. 2005. PMID: 16084231
-
Treatment options for osteoarthritis.Surg Technol Int. 2003;11:287-92. Surg Technol Int. 2003. PMID: 12931313 Review.
-
Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23. Pain Pract. 2008. PMID: 18503626
-
Update on the biology of the chondrocyte and new approaches to treating cartilage diseases.Best Pract Res Clin Rheumatol. 2006 Oct;20(5):1003-25. doi: 10.1016/j.berh.2006.06.003. Best Pract Res Clin Rheumatol. 2006. PMID: 16980220 Review.
-
Topical therapy for osteoarthritis: clinical and pharmacologic perspectives.Postgrad Med. 2009 Mar;121(2):139-47. doi: 10.3810/pgm.2009.03.1986. Postgrad Med. 2009. PMID: 19332972 Review.
Cited by
-
Liver X Receptor activation regulates genes involved in lipid homeostasis in developing chondrocytes.Osteoarthr Cartil Open. 2020 Jan 28;2(1):100030. doi: 10.1016/j.ocarto.2020.100030. eCollection 2020 Mar. Osteoarthr Cartil Open. 2020. PMID: 36474558 Free PMC article.
-
Human mesenchymal stromal cells release functional mitochondria in extracellular vesicles.Front Bioeng Biotechnol. 2022 Aug 19;10:870193. doi: 10.3389/fbioe.2022.870193. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 36082164 Free PMC article.
-
Validation of wearable visual feedback for retraining foot progression angle using inertial sensors and an augmented reality headset.J Neuroeng Rehabil. 2018 Aug 15;15(1):78. doi: 10.1186/s12984-018-0419-2. J Neuroeng Rehabil. 2018. PMID: 30111337 Free PMC article.
-
Chondroprotective Effects of a Standardized Extract (KBH-JP-040) from Kalopanax pictus, Hericium erinaceus, and Astragalus membranaceus in Experimentally Induced In Vitro and In Vivo Osteoarthritis Models.Nutrients. 2018 Mar 15;10(3):356. doi: 10.3390/nu10030356. Nutrients. 2018. PMID: 29543781 Free PMC article.
-
Image-guided optical spectroscopy in diagnosis of osteoarthritis: a clinical study.Biomed Opt Express. 2010 Jul 14;1(1):74-86. doi: 10.1364/BOE.1.000074. Biomed Opt Express. 2010. PMID: 21258447 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials